Raymed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve Financial results of the company ....
Awaiting price reaction for this filing.
Cresanto Global Ltd has informed BSE about a board meeting scheduled for Thursday, 22nd May 2025 at 3:00 PM at its Mumbai corporate office. The board will consider and approve the standalone audited financial results for the quarter and full year ended 31st March 2025, along with noting the auditor's report. The trading window for directors, officers, and connected persons remains closed from 1st April 2025 until 48 hours after results declaration, expected to reopen on 24th May 2025. Signed by Managing Director Prashant Nathmal Bajaj.
This is a routine regulatory filing ahead of the FY25 annual results announcement. No immediate impact on the stock price is expected from this intimation alone, but investors should watch the actual results on 22nd May 2025 for performance signals.